The Cannabist Company Holdings Inc. (OTCPK: CBST.Q)
Health Care · Pharmaceuticals · US
$0.00
-99.00% today · -100.0% 1Y
The Cannabist Company Holdings Inc. (OTCPK: CBST.Q) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $543.00 and employs 2,505 people.
Over the last twelve months the share price has lost 100.0%, trading between 0.00 and 0.16.
Tweenvest scores The Cannabist Company Holdings Inc. across four factors: quality 33/100, value 49/100, growth 56/100. Its strongest factor is growth.
CBST.Q price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $543.00
- Revenue (TTM)
- $349.84M
- P/E
- —
- EPS
- -0.37
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- $0.16
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 542.75M
- Employees
- 2,505
- Next earnings
- —
About The Cannabist Company Holdings Inc.
Columbia Care Inc. is a company operating in the cannabis sector, engaged in the cultivation, manufacturing, and distribution of a broad array of cannabis products and associated services. The firm's product lineup includes diverse forms such as flowers, edibles, oils, and tablets, marketed under its various proprietary brands, including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber, and Platinum Label CBD. The company holds essential licenses to conduct its operations across 18 distinct jurisdictions, encompassing territories within both the United States and the European Union. As of mid-June 2022, Columbia Care maintained an extensive operational footprint comprising 131 facilities; specifically, this included 99 retail dispensaries and 32 sites dedicated to cultivation and manufacturing processes. Columbia Care was established in 2012 and its corporate headquarters are situated in New York, New York.
- ISIN
- CA13765Y1034
- Founded
- 2012
- Listed since
- Mar 31, 2020
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,247.37 | -0.64% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $273.00 | +1.02% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $150.91 | -1.08% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.03 | -0.14% |
Figures last refreshed Aug 18, 2026.